Home > Share Market > Stocks > Aarti drugs > Financial Statements > AARTIDRUGS Key Financial Ratios

Aarti drugs Financial Statements

Aarti drugs Key Financial Ratios

  • Tabular Data
  • Graph
  • Consolidated
  • Standalone
Y/e 31 Mar Mar-2021 Mar-2020 Mar-2018 Mar-2017
Growth matrix (%)        
Revenue growth 19.30 45.20 4.05 4.85
Op profit growth 66.90 31.90 6.20 6.38
EBIT growth 82.60 34.50 4.61 9.54
Net profit growth 98.30 71.80 0.62 19
Profitability ratios (%)        
OPM 20.30 14.50 16 15.60
EBIT margin 18.20 11.90 12.80 12.80
Net profit margin 13 7.83 6.62 6.84
RoCE 31.80 19.50 15.70 16.60
RoNW 8.95 6.38 4.81 5.40
RoA 5.69 3.21 2.02 2.23
Per share ratios ()        
EPS 30.10 60.70 34.90 34.30
Dividend per share 2.50 2 1 1
Cash EPS 24.70 39.80 17.90 18.20
Book value per share 98 280 193 168
Valuation ratios        
P/E 23.10 2.08 3.63 4.20
P/CEPS 28.10 3.18 7.07 7.92
P/B 7.09 0.45 0.66 0.86
EV/EBIDTA 15.40 5.92 8.70 9.68
Payout (%)        
Dividend payout -- -- -- 2.92
Tax payout (24) (24) (34) (29)
Liquidity ratios        
Debtor days 88.40 87.30 98.60 96
Inventory days 62.70 61 71.60 59.20
Creditor days (70) (70) (80) (69)
Leverage ratios        
Interest coverage (17) (6.40) (4.60) (4.20)
Net debt / equity 0.37 0.58 1.19 1.19
Net debt / op. profit 0.78 1.46 2.73 2.54
Cost breakup ()        
Material costs (60) (64) (62) (64)
Employee costs (3.70) (3.80) (4.70) (4.40)
Other costs (16) (17) (18) (16)

OPEN A DEMAT ACCOUNT & Get
FREE Benefits Worth 5,000